Your browser doesn't support javascript.
loading
Regulatory mucosa-associated invariant T cells controlled by ß1 adrenergic receptor signaling contribute to hepatocellular carcinoma progression.
Fu, Sicheng; Liu, Muziying; Zhu, Chenwen; Zhang, Huimin; Zhao, Changfeng; Xie, Yaping; Chen, Guanghou; Sheng, Daping; Pan, Jun; He, Ziqing; Dai, Ying; Gao, Yufeng; Li, Xiaomei; Chen, Lijian; Qian, Yeben; Jin, Tengchuan; Sun, Cheng; Tian, Zhigang; Wang, Hua; Bai, Li.
Afiliación
  • Fu S; Division of Life Sciences and Medicine, Department of Oncology of the First Affiliated Hospital, the CAS Key Laboratory of Innate Immunity and Chronic Disease, University of Science and Technology of China, Hefei, China.
  • Liu M; School of Basic Medical Sciences, University of Science and Technology of China, Hefei, China.
  • Zhu C; Anhui Institute of Pediatric Research, Anhui Provincial Children's Hospital, Hefei, China.
  • Zhang H; Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Zhao C; Division of Life Sciences and Medicine, Department of Oncology of the First Affiliated Hospital, the CAS Key Laboratory of Innate Immunity and Chronic Disease, University of Science and Technology of China, Hefei, China.
  • Xie Y; School of Basic Medical Sciences, University of Science and Technology of China, Hefei, China.
  • Chen G; School of Basic Medical Sciences, University of Science and Technology of China, Hefei, China.
  • Sheng D; Department of Anesthesiology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Pan J; Department of General Surgery, Organ Transplantation Center, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • He Z; Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Dai Y; School of Basic Medical Sciences, University of Science and Technology of China, Hefei, China.
  • Gao Y; Department of Anesthesiology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Li X; Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Chen L; Department of Infectious Disease, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Qian Y; Division of Life Sciences and Medicine, Department of Rheumatology and Immunology, the First Affiliated Hospital, University of Science and Technology of China, Hefei, China.
  • Jin T; Department of Anesthesiology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Sun C; Department of General Surgery, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Tian Z; School of Basic Medical Sciences, University of Science and Technology of China, Hefei, China.
  • Wang H; School of Basic Medical Sciences, University of Science and Technology of China, Hefei, China.
  • Bai L; School of Basic Medical Sciences, University of Science and Technology of China, Hefei, China.
Hepatology ; 78(1): 72-87, 2023 07 01.
Article en En | MEDLINE | ID: mdl-36626624
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Células T Invariantes Asociadas a Mucosa / Neoplasias Hepáticas Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Hepatology Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Células T Invariantes Asociadas a Mucosa / Neoplasias Hepáticas Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Hepatology Año: 2023 Tipo del documento: Article País de afiliación: China